Brand check
Is Chymoral Forte banned in India?
Last checked 19 September 2026. A few details are still being checked against the original document.
Chymoral Forte is not banned in India as of 19 Sep 2026; CDSCO flagged batches 2KU6L057 and 2KU6L030 as potentially spurious in October 2025 and two further batches in December 2025, findings that concern counterfeits rather than the licence.
- Classification
- No ban or recall found in official records
- Decided by
- CDSCO / Ministry of Health and Family Welfare
- Reference
- No Section 26A notification; CDSCO monthly drug alerts, Oct 2025 and Dec 2025
- Latest action
- 21 January 2026
- Last checked
- 19 September 2026details being verified
Indian aceclofenac + paracetamol + serratiopeptidase tablet pack. Photo: Tainac-sp.jpg by Taionremedies (CC BY-SA 4.0). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.
Medical Dialogues: CDSCO flags 5 batches of widely used drugs including Azithral 500, Telma-AM as potentially spurious
We have not yet found this action in a published government document. Treat it as reported, not confirmed. If you have the order, send it to us.
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe explain what has been reported. The report above is the best source we hold.
Key facts
- Governing authority
- CDSCO, Ministry of Health and Family Welfare
- Ban notification
- None
- Oct 2025 alert
- Batches 2KU6L057 and 2KU6L030 potentially spurious; Torrent: under investigation
- Dec 2025 alert
- Two more Chymoral Forte batches declared spurious (published 21 Jan 2026)
- Halted 11 Apr 2025
- Trypsin-chymotrypsin + diclofenac + paracetamol / serratiopeptidase / MSM / boswellia combinations (not Chymoral Forte)
- Manufacturer
- Torrent Pharmaceuticals
Where the claim comes from
Two events. The April 2025 CDSCO halt of 35 unapproved combinations included several trypsin-chymotrypsin products combined with diclofenac and other actives, reported as 'trypsin-chymotrypsin combinations halted'. Then the October and December 2025 alerts named four Chymoral Forte batches as spurious. Between them, the leading enzyme brand looked banned.
Chymoral Forte is Torrent's trypsin-chymotrypsin tablet, an enzyme product prescribed after surgery and injury to reduce swelling. It is not banned.
Trypsin-chymotrypsin has never been named in a Section 26A notification. What happened on 11 April 2025 was that the CDSCO directed state licensing authorities to halt 35 fixed-dose combinations licensed without central approval, and several of them paired trypsin-chymotrypsin with diclofenac and paracetamol, serratiopeptidase, methylsulfonylmethane or boswellia. Those are multi-drug products from other manufacturers, not Chymoral Forte, which contains the enzyme alone.
The brand's own news is about counterfeits. The CDSCO's alert for October 2025 listed batches 2KU6L057 and 2KU6L030 of Chymoral Forte among five batches of well-known brands considered potentially spurious; Torrent said the matter was under investigation. The alert for December 2025, published on 21 January 2026, declared two more Chymoral Forte batches spurious, alongside Telma-AM, Telma 40, Montina-L and Pantop-D. "Spurious" means the sample was not what its label claimed, a fake carrying the brand's name, and manufacturers' standard response is that they did not make the batch.
For patients, the licence is unchanged. The practical steps are to buy from a licensed pharmacy with a bill, compare the batch number on the strip with the four listed, and, as a separate clinical question, ask a doctor whether an oral enzyme is adding anything to recovery.
What this means for you
The product is licensed and on sale
Chymoral Forte has not been banned or halted.
Read the two statements side by side
CDSCO's finding is batch-specific. The company says the batch was not made by it, i.e. counterfeit. Both can be true: someone else made a fake pack with the brand's name.
Compare your batch
If it matches 2KU6L057, 2KU6L030 or the December 2025 batches, do not use it and show your pharmacist.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Batches flagged in CDSCO alerts
Products whose name matches this brand or molecule in CDSCO monthly NSQ alerts. A flagged batch is a single batch; the company's response, where reported, is noted on the page above.
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Trypsin-Chymotrypsin Tablets | 2KU6M021Mfg 2025-05 · Exp 2028-04 | Torrent Pharmaceuticals LtdSikkim | The sample does not conform to Manufacturer's specification with respect to Assay of Trypsin-Chymotrypsin activity.Assay | CDL KolkataCDSCO lab | Jun 2026 |
| Trypsin-Chymotrypsin Tablets (CHYMORAL FORTE DS) | WBB1E020Mfg 2024-12 · Exp 2026-11 | Windlas Biotech Ltd. (Plant-2) Khasra No. 141 To 143 & 145Uttarakhand | The sample is not of standard quality for the reason stated under 'Description'.Description | CDL, KolkataCDSCO lab | Oct 2025 |
| Trypsin-Chymotrypsin Tablets (Chymnetra-Forte) | DT1624HMfg 2022-12 · Exp 2024-11 | DM PHARMA PRIVATE LIMITEDHimachal Pradesh | Uniformity of Weight, & Average WeightUniformity of weight/content | CDTL MumbaiCDSCO lab | Jul 2023 |
| Trypsin- Chymotrypsin Tablets (CHYMORAL FORTE TABLETS) | 2JH3H019Mfg 2021-04 · Exp 2023-03 | Nestor Pharmaceuticals LimitedHaryana | Disintegration test (Acid Medium)Disintegration | RDTL ChandigarhState lab | Jan 2023 |
Official sources and primary records
- Medical Dialogues: CDSCO flags 5 batches of widely used drugs including Azithral 500, Telma-AM as potentially spuriousNewsMedical Dialogues
- Business Standard: CDSCO flags 7 drugs as spurious, 167 fail quality tests in Dec 2025NewsBusiness Standard · 21 January 2026
- Business Today: India halts 35 drug combinations over health risks, full listNewsBusiness Today · 17 April 2025
- Outlook Business: Linking spurious drugs with legitimate manufacturers has severe reputational, financial impact. IPANewsOutlook Business